Consistent with the previous understanding that tumour‐derived CCL19 inhibited the CD8 T cell and promoted lymph node metastasis,35 we hypothesize NPC tumour cells will release CCL19 and reshape the immunosuppressive TIME of metastatic lymph nodes via CCR7. This evidence concerns the gene CCL19 and neoplasm.